Thanks for emailing that article!
Adrienne L. Graves, PhD is a visual scientist by training and a global industry leader in ophthalmology.
From 2002 to 2010, Dr. Graves was President and Chief Executive Officer of Santen Inc., the US arm of Japan’s largest ophthalmic pharmaceutical company. She joined Santen in 1995 as VP of Clinical Affairs to initiate clinical development in the US, and was responsible for 3 NDA approvals. She was promoted to Sr. VP of Worldwide Clinical Affairs (Japan, US, and Europe), and was subsequently named a global Corporate Officer and CEO of US operations. Prior to joining Santen, Dr. Graves spent nine years with Alcon Laboratories, Inc., beginning in 1986 as a Senior Scientist. She progressed through various roles, including Director of International Ophthalmology.
Dr. Graves currently serves as an Independent Director on the following corporate boards: Akorn, Inc., Nicox S.A., Surface Pharmaceuticals, and TearLab Corporation. She is also a Director on the following Foundation Boards: American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology (AAO) Foundation (Emeritus), Himalayan Cataract Project, Pan-American Ophthalmology Foundation, and KeepYourSight Foundation; she also serves on the Corporation Committee for the Brown University Medical School and the Advisory Board for Amach Capital Partners.
Dr. Graves cofounded Glaucoma 360 (Glaucoma Research Foundation) and Ophthalmic Women Leaders (OWL). She received her AB in Psychology with honors from Brown University, her PhD in Psychobiology from the University of Michigan, and she completed a postdoctoral fellowship in visual neuroscience at the University of Paris.
In 2015, Glaucoma Research Foundation presented The Catalyst Award to Dr. Graves in recognition of her outstanding leadership and many contributions to ophthalmology and for her dedicated service on the GRF Board of Directors. She currently serves on the Glaucoma Research Foundation Board's Research Committee and Chairs the Board Leadership Committee.